Published in Cent Nerv Syst Agents Med Chem on March 01, 2009
Depression and risk of developing dementia. Nat Rev Neurol (2011) 2.31
Markers of Oxidative Stress and Neuroprogression in Depression Disorder. Oxid Med Cell Longev (2015) 0.88
Antidepressants reduce neuroinflammatory responses and astroglial alpha-synuclein accumulation in a transgenic mouse model of multiple system atrophy. Glia (2013) 0.87
New insight into the antidepressants action: modulation of kynurenine pathway by increasing the kynurenic acid/3-hydroxykynurenine ratio. J Neural Transm (Vienna) (2011) 0.85
Anti-inflammatory Activity of 1-docosanoyl Cafferate Isolated from Rhus verniciflua in LPS-stimulated BV2 Microglial Cells. Korean J Physiol Pharmacol (2011) 0.83
Immunomodulation Mechanism of Antidepressants: Interactions between Serotonin/Norepinephrine Balance and Th1/Th2 Balance. Curr Neuropharmacol (2012) 0.83
Accelerated aging in major depression: the role of nitro-oxidative stress. Oxid Med Cell Longev (2013) 0.80
Selective serotonin reuptake inhibitors attenuate the antigen presentation from dendritic cells to effector T lymphocytes. FEMS Immunol Med Microbiol (2011) 0.79
Effect of venlafaxine on experimental colitis in normal and reserpinised depressed rats. Res Pharm Sci (2015) 0.75
Fluoxetine Prevents Aβ1-42-Induced Toxicity via a Paracrine Signaling Mediated by Transforming-Growth-Factor-β1. Front Pharmacol (2016) 0.75
Beneficial Effects of Maprotiline in a Murine Model of Colitis in Normal and Reserpinised Depressed Rats. Int Sch Res Notices (2014) 0.75
Anti-inflammatory Effect of Amitriptyline on Ulcerative Colitis in Normal and Reserpine-Induced Depressed Rats. Iran J Pharm Res (2016) 0.75
Huanglian-Jie-Du-Tang Extract Ameliorates Depression-Like Behaviors through BDNF-TrkB-CREB Pathway in Rats with Chronic Unpredictable Stress. Evid Based Complement Alternat Med (2017) 0.75
The ALS/PDC syndrome of Guam and the cycad hypothesis. Neurology (2008) 3.64
Antidepressant medications and other treatments of depressive disorders: a CINP Task Force report based on a review of evidence. Int J Neuropsychopharmacol (2007) 2.60
The effect of atypical antipsychotics, perospirone, ziprasidone and quetiapine on microglial activation induced by interferon-gamma. Prog Neuropsychopharmacol Biol Psychiatry (2007) 2.50
Randomised, double-blind, placebo-controlled study of olanzapine in patients with bipolar I depression. Br J Psychiatry (2012) 2.21
Inflammatory processes in Alzheimer's disease. Prog Neuropsychopharmacol Biol Psychiatry (2003) 2.04
The International Society for Bipolar Disorders (ISBD) task force report on antidepressant use in bipolar disorders. Am J Psychiatry (2013) 1.97
The International Society for Bipolar Disorders (ISBD) Task Force report on the nomenclature of course and outcome in bipolar disorders. Bipolar Disord (2009) 1.91
Inflammation, the complement system and the diseases of aging. Neurobiol Aging (2005) 1.70
Neuroinflammation in Alzheimer's disease and mild cognitive impairment: a field in its infancy. J Alzheimers Dis (2010) 1.68
PrP conformational transitions alter species preference of a PrP-specific antibody. J Biol Chem (2010) 1.62
Colocalization of transactivation-responsive DNA-binding protein 43 and huntingtin in inclusions of Huntington disease. J Neuropathol Exp Neurol (2008) 1.56
Altered face inversion effect and association between face N170 reduction and social dysfunction in patients with schizophrenia. Clin Neurophysiol (2012) 1.48
Reduction of human monocytic cell neurotoxicity and cytokine secretion by ligands of the cannabinoid-type CB2 receptor. Br J Pharmacol (2003) 1.47
LRRK2 expression in normal and pathologic human brain and in human cell lines. J Neuropathol Exp Neurol (2006) 1.46
No association between genotype of the promoter region of serotonin transporter gene and serotonin transporter binding in human brain measured by PET. Synapse (2003) 1.44
Cytokines and schizophrenia: Microglia hypothesis of schizophrenia. Psychiatry Clin Neurosci (2009) 1.43
SSRI-induced enuresis: a case report. J Clin Psychopharmacol (2004) 1.42
Brain activation of patients with obsessive-compulsive disorder during neuropsychological and symptom provocation tasks before and after symptom improvement: a functional magnetic resonance imaging study. Biol Psychiatry (2005) 1.41
Abeta and tau form soluble complexes that may promote self aggregation of both into the insoluble forms observed in Alzheimer's disease. Proc Natl Acad Sci U S A (2006) 1.41
Peritraumatic Distress Inventory as a predictor of post-traumatic stress disorder after a severe motor vehicle accident. Psychiatry Clin Neurosci (2010) 1.38
Severe vascular disturbance in a case of familial brain calcinosis. Acta Neuropathol (2005) 1.38
Therapeutic approaches to inflammation in neurodegenerative disease. Curr Opin Neurol (2007) 1.38
SARS corona virus peptides recognized by antibodies in the sera of convalescent cases. Virology (2004) 1.29
Microglial PHOX and Mac-1 are essential to the enhanced dopaminergic neurodegeneration elicited by A30P and A53T mutant alpha-synuclein. Glia (2007) 1.26
Inflammatory aspects of Alzheimer disease and other neurodegenerative disorders. J Alzheimers Dis (2008) 1.24
Alpha-synuclein activates stress signaling protein kinases in THP-1 cells and microglia. Neurobiol Aging (2006) 1.24
Amyloid-beta42 interacts mainly with insoluble prion protein in the Alzheimer brain. J Biol Chem (2011) 1.22
Axonal damage and demyelination in the white matter after chronic cerebral hypoperfusion in the rat. Brain Res (2002) 1.21
Effects of hydrogen sulfide-releasing L-DOPA derivatives on glial activation: potential for treating Parkinson disease. J Biol Chem (2010) 1.20
Lrrk2 phosphorylates alpha synuclein at serine 129: Parkinson disease implications. Biochem Biophys Res Commun (2009) 1.20
Reliability and validity of the Japanese version of the Peritraumatic Distress Inventory. Gen Hosp Psychiatry (2008) 1.20
Astrocytes are GABAergic cells that modulate microglial activity. Glia (2011) 1.19
Neuroinflammation in schizophrenia especially focused on the role of microglia. Prog Neuropsychopharmacol Biol Psychiatry (2011) 1.19
Depletion of GSH in glial cells induces neurotoxicity: relevance to aging and degenerative neurological diseases. FASEB J (2010) 1.18
Persisting atypical and cystic forms of Borrelia burgdorferi and local inflammation in Lyme neuroborreliosis. J Neuroinflammation (2008) 1.18
Transgenic mice overexpressing amyloid beta protein are an incomplete model of Alzheimer disease. Exp Neurol (2004) 1.18
Assessment of the dexamethasone/CRH test as a state-dependent marker for hypothalamic-pituitary-adrenal (HPA) axis abnormalities in major depressive episode: a Multicenter Study. Neuropsychopharmacology (2006) 1.17
Alpha-synuclein and its disease-causing mutants induce ICAM-1 and IL-6 in human astrocytes and astrocytoma cells. FASEB J (2006) 1.17
Risperidone significantly inhibits interferon-gamma-induced microglial activation in vitro. Schizophr Res (2007) 1.15
Astrocytes produce the antiinflammatory and neuroprotective agent hydrogen sulfide. Neurobiol Aging (2009) 1.14
Midlife and late-life blood pressure and dementia in Japanese elderly: the Hisayama study. Hypertension (2011) 1.12
Antidepressants inhibit interferon-gamma-induced microglial production of IL-6 and nitric oxide. Exp Neurol (2007) 1.11
Genetic dissection of medial habenula-interpeduncular nucleus pathway function in mice. Front Behav Neurosci (2013) 1.10
Expression of BRI, the normal precursor of the amyloid protein of familial British dementia, in human brain. Acta Neuropathol (2003) 1.10
Thrombin and prothrombin are expressed by neurons and glial cells and accumulate in neurofibrillary tangles in Alzheimer disease brain. J Neuropathol Exp Neurol (2006) 1.09
Depletion of intracellular Ca2+ store itself may be a major factor in thapsigargin-induced ER stress and apoptosis in PC12 cells. Neurochem Int (2006) 1.09
Suppression of cell proliferation by interferon-alpha through interleukin-1 production in adult rat dentate gyrus. Neuropsychopharmacology (2006) 1.09
Eating disorders with binge-eating behaviour are associated with the s allele of the 3'-UTR VNTR polymorphism of the dopamine transporter gene. J Psychiatry Neurosci (2004) 1.08
Inhibitory effects of aripiprazole on interferon-gamma-induced microglial activation via intracellular Ca2+ regulation in vitro. J Neurochem (2008) 1.07
Cyclooxygenase and 5-lipoxygenase inhibitors protect against mononuclear phagocyte neurotoxicity. Neurobiol Aging (2002) 1.06
Effect of yokukansan on the behavioral and psychological symptoms of dementia in elderly patients with Alzheimer's disease. Prog Neuropsychopharmacol Biol Psychiatry (2008) 1.05
Functional MRI study of brain activation alterations in patients with obsessive-compulsive disorder after symptom improvement. Psychiatry Res (2008) 1.05
International consensus statement on major depressive disorder. J Clin Psychiatry (2010) 1.05
Pharmacologic approaches to the treatment of amyotrophic lateral sclerosis. BioDrugs (2005) 1.05
Beta amyloid and hyperphosphorylated tau deposits in the pancreas in type 2 diabetes. Neurobiol Aging (2008) 1.03
Arterial spin labelling at 3-T MR imaging for detection of individuals with Alzheimer’s disease. Eur Radiol (2009) 1.03
Inflammation in transgenic mouse models of neurodegenerative disorders. Biochim Biophys Acta (2009) 1.01
Functional characterization of mismatch negativity to a visual stimulus. Clin Neurophysiol (2005) 1.01
Non-steroidal anti-inflammatory drugs (NSAIDs) and other anti-inflammatory agents in the treatment of neurodegenerative disease. Curr Alzheimer Res (2005) 1.01
Proteolysis of non-phosphorylated and phosphorylated tau by thrombin. J Biol Chem (2004) 1.00
Aconiti tuber increases plasma nitrite and nitrate levels in humans. J Ethnopharmacol (2005) 1.00
Impairment of theory of mind in patients in remission following first episode of schizophrenia. Eur Arch Psychiatry Clin Neurosci (2006) 0.99
High prevalence of anxiety and depression in patients with primary open-angle glaucoma. J Glaucoma (2008) 0.99
Hydrogen sulfide-releasing NSAIDs attenuate neuroinflammation induced by microglial and astrocytic activation. Glia (2010) 0.99
Characterization of human and mouse TRPM2 genes: identification of a novel N-terminal truncated protein specifically expressed in human striatum. Biochem Biophys Res Commun (2005) 0.98
Specificity of mechanisms for plaque removal after A beta immunotherapy for Alzheimer disease. Nat Med (2004) 0.98
Mechanisms of GABA release from human astrocytes. Glia (2011) 0.96
Immuno-inflammatory, oxidative and nitrosative stress, and neuroprogressive pathways in the etiology, course and treatment of schizophrenia. Prog Neuropsychopharmacol Biol Psychiatry (2012) 0.96
Expression of complement messenger RNAs and proteins by human oligodendroglial cells. Glia (2003) 0.96
Visual and auditory hallucinations during normal use of paroxetine for treatment of major depressive disorder. J Neuropsychiatry Clin Neurosci (2011) 0.96
A population-specific uncommon variant in GRIN3A associated with schizophrenia. Biol Psychiatry (2012) 0.96
Deficiency of theory of mind in patients with remitted mood disorder. J Affect Disord (2004) 0.96
Working memory dysfunction in obsessive-compulsive disorder: a neuropsychological and functional MRI study. J Psychiatr Res (2008) 0.95
Aripiprazole inhibits superoxide generation from phorbol-myristate-acetate (PMA)-stimulated microglia in vitro: implication for antioxidative psychotropic actions via microglia. Schizophr Res (2011) 0.94
The genetic structure of Cloninger's seven-factor model of temperament and character in a Japanese sample. J Pers (2002) 0.94
Does the 'hikikomori' syndrome of social withdrawal exist outside Japan? A preliminary international investigation. Soc Psychiatry Psychiatr Epidemiol (2011) 0.94
Interferon-gamma-dependent cytotoxic activation of human astrocytes and astrocytoma cells. Neurobiol Aging (2008) 0.93
Inhibitory effects of SSRIs on IFN-γ induced microglial activation through the regulation of intracellular calcium. Prog Neuropsychopharmacol Biol Psychiatry (2010) 0.93
Risk factors for anxiety and depression in patients with glaucoma. Br J Ophthalmol (2012) 0.91
Potential impact of propofol immediately after motor vehicle accident on later symptoms of posttraumatic stress disorder at 6-month follow up: a retrospective cohort study. Crit Care (2012) 0.91
Development of 2-hour suicide intervention program among medical residents: first pilot trial. Psychiatry Clin Neurosci (2010) 0.91
Enduring involvement of tau, beta-amyloid, alpha-synuclein, ubiquitin and TDP-43 pathology in the amyotrophic lateral sclerosis/parkinsonism-dementia complex of Guam (ALS/PDC). Acta Neuropathol (2008) 0.91
Brain-derived neurotrophic factor induces sustained elevation of intracellular Ca2+ in rodent microglia. J Immunol (2009) 0.91
The new GRID Hamilton Rating Scale for Depression demonstrates excellent inter-rater reliability for inexperienced and experienced raters before and after training. Psychiatry Res (2007) 0.90
Cerebral white matter degeneration in frontotemporal dementia detected by diffusion-weighted magnetic resonance imaging. Acad Radiol (2006) 0.90
Abnormal neural oscillatory activity to speech sounds in schizophrenia: a magnetoencephalography study. J Neurosci (2008) 0.90
Reduced high and low frequency gamma synchronization in patients with chronic schizophrenia. Schizophr Res (2011) 0.90
Are Japan's hikikomori and depression in young people spreading abroad? Lancet (2011) 0.89
Apolipoprotein genotype for prediction of Alzheimer's disease in older Japanese: the Hisayama Study. J Am Geriatr Soc (2011) 0.89